University of California, Davis
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Davis sits in the top decile of US sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count).
University of California, Davis: 657 sponsored US clinical trials, 123 recruiting.
University of California, Davis sponsors 657 registered US clinical trials on ClinicalTrials.gov, 123 of them currently recruiting, and 435 completed. 38 of these trials are in Phase 3-4 (later-stage) and 129 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 12 trials.
Top-decile sponsor footprint
University of California, Davis ranks in the top decile of sponsors by registered trial count (#52 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
435 of 483 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
657 total, page 7 of 14
A Feasibility Study to Determine PET/CT Imaging of Blood Flow to the Bone
NCT03557450
Orange Juice And Sugar Intervention Study
NCT03527277
Pediatric Bronchiolitis Quality Improvement
NCT03528083
Diaphragmatic Breathing and Heart Rate Variability Training for Improving Hypertension in Fragile X Associated Tremor/Ataxia
NCT03816540
A Trial of Metformin in Individuals With Fragile X Syndrome
NCT03479476
Nonrandomized Evaluation of a Multidimensional Behavioral Intervention
NCT03717597
Micropulse for Suppression of Diabetic Macular Edema
NCT03519581
Use of Virtual Reality Game Playing During Venipuncture
NCT03518346
Effects of Prolonged Fasting on Microbiome and HDL
NCT03487679
Acute Assessment of Platelet Reactivity After the Intake of Oleocanthal
NCT03528603
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
NCT03461445
Daily Intake of Cocoa Flavanols and Arterial Stiffness in Humans
NCT03587883
Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin
NCT03477825
Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department
NCT02899065
Comparison of Cosmetic Outcomes of Straight Line and W-plasty Techniques for Linear Wound Closure
NCT05074199
Effects of Mindfulness-Based Stress Reduction on Knee Osteoarthritis
NCT03527849
UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma
NCT03322384
A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy
NCT03320226
Virological Suppression in HIV Positive Patients Involved in a Novel Standardized Adherence Protocol
NCT03517358
Predicting Fluid Responsiveness Using Transiently Increased Intrathoracic Pressure in Mechanically Ventilated Patients
NCT03413657
Cabazitaxel and Prednisone in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
NCT02844582
Cosmetic Effects of Topical Acetyl Zingerone
NCT03530787
Comparison of Etomidate Plus Propofol, Etomidate Alone on Induction of Anesthesia
NCT03820388
The Influence of Personal Care Products on the Skin Microbiome
NCT03819179
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
NCT03359460
Home Visits to Optimize Medical and Educational Success Among Sacramento Schoolchildren With Asthma
NCT03335046
Type 1 Diabetes Telemedicine
NCT03374462
Validation of an Automated Online Language Interpreting Tool - Phase Two.
NCT03538860
Lipidome and Microbiome Profile of the Eye in Rosacea
NCT03655197
Improving Communication About Pain and Opioids
NCT03629197
Gelatin, Collagen, Gummy and PINP
NCT03357432
Suturing Distance From the Wound Edge, 2 mm vs 5 mm
NCT03330041
Specifying and Treating Anxiety in Autism Research
NCT03279471
Interrupted Subdermal Suture Spacing During Linear Wound Closures and the Effect on Wound Cosmesis
NCT03327922
Collagen Vitamin C Dose Response Performance
NCT03293004
Virtual Reality Distraction for Anxiety Reduction During Trigger Points Procedures in Pain Medicine Clinic
NCT03334929
Modified Pre-operative Oral Doses Acetaminophen Versus Intravenous Acetaminophen
NCT02994940
UCDCC#269: A Pilot Study of Interlesional IL-2 and RT in Patients With NSCLC.
NCT03224871
Influence of Freeze Dried Strawberry Consumption on Gut Microbiota and Cardiovascular Health.
NCT03283969
Glycemic Index of Table Grape Varietals
NCT03248609
CCRO044: Quality of Life Assessments Associated With a Physician Communication Intervention for Prostate Cancer Patients
NCT03780023
Comparison of Asynchronous Telepsychiatry vs. Synchronous Telepsychiatry in Skilled Nursing Facilities
NCT03264560
Assessment of a New Food Product in Metabolically at Risk Children
NCT03175003
INdividualized ITI Based on Fviii(ATE) Protection by VWF
NCT03204539
Effects of Epicatechin-rich Cocoa on Collagen Synthesis
NCT03214133
Vietnamese Caregiver Intervention Study
NCT03218982
CO2 Laser Phototherapy for Management of Mature Burn Scars
NCT03197649
PUMP (Providing the Underprivileged With Manual Pumps): An RCT
NCT03192241
Pediatric Ward Discharge Quality Improvement
NCT03153722
Acupuncture and Acupressure for Postoperative Nausea and Vomiting in Children Undergoing Outpatient Middle Ear Surgery
NCT03380182
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 86 |
| Phase 2 | 43 |
| Phase 3 | 10 |
| Phase 4 | 28 |
Therapeutic Areas
What is open in the University of California, Davis pipeline
123 recruiting of 657 indexed (19% open); 435 completed (66%).
Phase mix: 38 late (III/IV) vs 129 early (I/II) (early-phase heavy).
Top condition: Healthy (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Davis: open-pipeline peers nationwide
Peers matched on 657 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of California, Davis sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 657 trials (± recruiting share)
- Vanderbilt University Medical Center · 677 trials · 19% recruiting
- University of Rochester · 636 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- The Cleveland Clinic · 688 trials · 14% recruiting
Sponsors near 19% open enrollment (± trial volume)
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
- Insulet Corporation · 19% recruiting · 16 trials
- Medical University of South Carolina · 19% recruiting · 755 trials
Related
What to do with this University of California, Davis page
657 registered trials is a research-attention snapshot, not an endorsement of University of California, Davis or any single study.
- 123 of University of California, Davis's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of California, Davis studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Davis pipeline card: 657 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.